Want to see JP:3101 full AI Analyst Report?
3101 Stock Chart & Stats
¥1275.00
-¥4.00(-0.42%)
At close: 4:00 PM EST
¥1275.00
-¥4.00(-0.42%)
Day’s Range― - ―
52-Week Range¥980.00 - ¥1,945.00
Previous CloseN/A
Volume273.20K
Average Volume (3M)305.73K
Market Cap
¥135.12B
Enterprise Value¥384.80K
Total Cash (Recent Filing)¥30.79B
Total Debt (Recent Filing)¥265.12B
Price to Earnings (P/E)12.0
Beta1.09
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.63%
Share Statistics
EPS (TTM)31.66
Shares Outstanding89,048,790
10 Day Avg. Volume223,990
30 Day Avg. Volume305,730
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.54
Price to Sales (P/S)0.28
P/FCF Ratio8.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)117.31
Revenue Forecast (FY)¥456.32B
Bulls Say, Bears Say
Bulls Say
Diversified Materials PortfolioToyobo's multi-domain materials footprint (films, functional polymers, industrial materials, textiles) spreads revenue across end markets. This structural diversification reduces reliance on any single cyclical sector, supports cross-selling, and helps stabilize revenue through industry cycles over the medium term.
Sustained Revenue ExpansionA multi-year revenue increase with a material step-up by 2025–2026 indicates expanding scale and customer demand across product lines. Sustained top-line growth provides a base for margin recovery, investment in new products, and underwriting of fixed costs, improving structural competitiveness if maintained.
Improving Cash GenerationThe rebound in operating cash flow and return to positive free cash flow in 2026 reflects improved cash conversion and lower reliance on external financing. If sustained, stronger FCF supports deleveraging, targeted capex, dividends, or strategic R&D, enhancing long-term financial flexibility.
Bears Say
Elevated LeverageLeverage running above equity leaves the company exposed to interest costs and reduces buffer for cyclical downdrafts. High absolute debt limits strategic optionality, raises refinancing risk if credit markets tighten, and constrains capacity for aggressive share repurchase or large M&A without deleveraging.
Volatile ProfitabilityEarnings have been uneven, indicating sensitivity to input costs, pricing, or cyclical end markets. This makes forecasting EBITDA and cash returns unreliable, complicates capital allocation and investor visibility, and increases the risk that a future cycle could quickly erode margins again.
Multi-year Negative Free Cash Flow HistoryA history of negative free cash flow implies sustained heavy investment or working-capital strain and reliance on financing during weaker periods. Even with 2026 improvement, the prior pattern raises questions about cash conversion sustainability and the firm's ability to fund growth without rebuilding leverage headroom.
Toyobo Co News
3101 FAQ
What was Toyobo Co Ltd’s price range in the past 12 months?
Toyobo Co Ltd lowest stock price was ¥980.00 and its highest was ¥1945.00 in the past 12 months.
What is Toyobo Co Ltd’s market cap?
Toyobo Co Ltd’s market cap is ¥135.12B.
When is Toyobo Co Ltd’s upcoming earnings report date?
Toyobo Co Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 2 days.
How were Toyobo Co Ltd’s earnings last quarter?
Toyobo Co Ltd released its earnings results on May 12, 2026. The company reported ¥37.93 earnings per share for the quarter, beating the consensus estimate of N/A by ¥37.93.
Is Toyobo Co Ltd overvalued?
According to Wall Street analysts Toyobo Co Ltd’s price is currently Overvalued.
Does Toyobo Co Ltd pay dividends?
Toyobo Co Ltd pays a Annually dividend of ¥40 which represents an annual dividend yield of 2.63%. See more information on Toyobo Co Ltd dividends here
What is Toyobo Co Ltd’s EPS estimate?
Toyobo Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Toyobo Co Ltd have?
Toyobo Co Ltd has 89,048,790 shares outstanding.
What happened to Toyobo Co Ltd’s price movement after its last earnings report?
Toyobo Co Ltd reported an EPS of ¥37.93 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.066%.
Which hedge fund is a major shareholder of Toyobo Co Ltd?
Currently, no hedge funds are holding shares in JP:3101
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Toyobo Co Ltd
Established in 1882 and headquartered in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise delivering a diverse range of products. The company specializes in the manufacturing of films and advanced polymers, industrial components, healthcare solutions, and various textile goods. Its films and functional polymers division produces industrial PET films for applications such as liquid crystal displays and optics, in addition to synthetic papers. It also supplies a variety of packaging films, including PET, polyolefin, and nylon options for food products, along with heat-shrink PET films. The company's portfolio of functional polymers features engineering plastics, industrial adhesives, specialized coatings, photosensitive printing plates, acrylate polymers, and electronic materials. This segment further encompasses rubber and coat processing, as well as pharmaceutical intermediates. Within its industrial materials segment, Toyobo develops functional fibers for airbag construction, polyethylene fibers, and PBO fibers. It also creates functional filters for automotive and indoor environments, materials for anti-pollution solvent adsorption, and fiber components utilized in vehicle parts. In the healthcare sector, the company provides a comprehensive selection of bio-products, which includes enzymes for diagnostic purposes, diagnostic systems, and research reagents. Its contributions also extend to artificial kidney hollow fibers, anti-clotting substances, and seawater desalination modules. For textiles, Toyobo supplies functional fabrics suitable for sports clothing, undergarments, and uniforms, alongside synthetic filaments. The company markets apparel under its Munsingwear brand, acrylic fibers under Exlan, and acrylate fibers under the eks brand, while also engaging in general textile product commerce. Beyond these offerings, Toyobo serves as a contract manufacturer for injectable pharmaceuticals.